PLXNA3 and metabolic syndrome: The sex difference in the prevalence of NAFLD might be caused by the difference of tissue vulnerability on the proinflammatory/profibrotic cytokines, the effect of sex hormone, or the differences in the comorbid condition such as obesity, insulin resistance, and dyslipidemia.